Bioversys AG Financial Flexibility Index
Bioversys AG financial flexibility index. Bioversys AG (BIOV) has a Financial Flexibility Index of -0.70x as of December 2025. Free cash flow of CHF-21.73 Million (operating CF CHF-21.95 Million minus capex CHF216.00K) represents -1% of total liabilities (CHF30.82 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Bioversys AG (2024–2025)
Financial flexibility index of Bioversys AG from 2024 to 2025. Historical Financial Flexibility Index trend for Bioversys AG across 2 annual periods. Explore BIOV operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Bioversys AG Financial Flexibility Index by Year (2024–2025)
Bioversys AG financial flexibility index by year from 2024 to 2025. Year-by-year free cash flow to debt coverage for Bioversys AG. For the full cash flow conversion analysis, see BIOV operating cash flow.
| Year | Flexibility Index | Free Cash Flow (CHF) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.70x | CHF-21.73 Million | CHF-21.95 Million | CHF30.82 Million | ▼ -10.1% |
| 2024 | -0.64x | CHF-15.54 Million | CHF-15.57 Million | CHF24.27 Million | — |